Skip to main content

Table 3 Crude and adjusted mean alveolar bone loss (mm) for both groups over time

From: Annual alveolar bone loss in older adults taking oral bisphosphonate: a retrospective cohort study

Variables

Adjusted MABL (mm)a

95% CI

p-value

Unadjusted MABL (mm)a

95% CI

p-value

YearaBIS

 0 No BIS (reference)

    

 2 No BIS

−0.027(−0.08,0.03)

0.374

−0.027(−0.08,0.03)

0.383

 0 BIS+

0.084(−0.16,0.033)

0.515

−0.059(− 0.27,0.15)

0.594

 2 BIS+

0.088 (0.001,0.176)

0.048

0.087(−0.0002,0.175)

0.051

Age (continious yrs)

 1 year increase

− 0.002(− 0.016,0.012)

0.764

  

Gender

 Female (reference)

    

 Male

−0.312(− 0.830,0.204)

0.236

  

Race

 White (reference)

    

 African American

0.476(−0.244,1.198)

0.195

  

 Asian

0.092(−0.246,0.432)

0.591

  

 Other

−0.289(− 0.708,0.129)

0.176

  

 Unknown

−0.108(− 0.348,0.130)

0.373

  

Median House Incomea

 Low (reference)

    

 High

−0.153(−0.405,0.098)

0.233

  

Body Mass Index

 Underweight/Normal (reference)

    

 Overweight/Obese

−0.235(−0.476,0.004)

0.055

  

Smoking Status

 Never smoker (reference)

    

 Former smoker

0.153(−0.199,0.505)

0.394

  

 Current Smoker

n/a

n/a

  

CVD

 No (reference)

    

 Yes

0.133(−0.165,0.433)

0.381

  

Hypertension

 No (reference)

    

 Yes

−0.118(−0.388,0.150)

0.388

  

D4341

 No (reference)

    

 Yes

0.113(−0.169,0.396)

0.433

  

Random effect

 Between Individuals

0.14 (0.10,0.17)

n/a

  

 Between Teeth

0.12 (0.10,0.13)

n/a

  

 Between Sites

0.21 (0.19,0.22)

n/a

  
  1. N = 52 patients (2307 sites from 658 teeth)
  2. aMean alveolar bone loss in millimeter